Farmson Basic Drugs is expanding its API portfolio by venturing into the manufacturing of caffeine. Known for its commitment to quality and innovation, Farmson Basic Drugs will produce high-purity caffeine through a process involving seven distinct chemical conversions. This strategic addition strengthens Farmson’s position as a leading pharmaceutical ingredient manufacturer, ensuring consistent, reliable, and top-grade products for its global partners.
Read more from our blog: https://www.farmson.com/blogs/farmson-expands-its-api-portfolio-will-now-manufacture-caffeine/
No comments:
Post a Comment